| Entry |
|
|---|
| Name |
Trandolapril (JAN/USP/INN);
Mavik (TN) |
|---|
| Product |
|
|---|
| Generic |
|
|---|
| Formula |
C24H34N2O5
|
|---|
| Exact mass |
430.2468
|
|---|
| Mol weight |
430.5372
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Cardiovascular agent
DG01925 Renin-angiotensin system inhibitor
DG01501 Angiotensin-converting enzyme inhibitor
DG03231 Antihypertensive
DG01501 Angiotensin-converting enzyme inhibitor
|
|---|
| Remark |
| Therapeutic category: | 2144 |
| Product (mixture): | D10282<US> |
|
|---|
| Efficacy |
Antihypertensive, Angiotensin-converting enzyme inhibitor |
|---|
| Disease |
|
|---|
| Comment |
Active form of prodrug: Trandolaprilat [CPD: C21515]
|
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
C CARDIOVASCULAR SYSTEM
C09 AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
C09A ACE INHIBITORS, PLAIN
C09AA ACE inhibitors, plain
C09AA10 Trandolapril
D00383 Trandolapril (JAN/USP/INN) <JP/US>
USP drug classification [BR:br08302]
Cardiovascular Agents
Angiotensin-converting Enzyme (ACE) Inhibitors
Trandolapril
D00383 Trandolapril (JAN/USP/INN)
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
21 Cardiovascular agents
214 Antihypertensives
2144 Angiotensin converting enzyme inhibitors
D00383 Trandolapril (JAN/USP/INN)
Drug groups [BR:br08330]
Cardiovascular agent
DG01925 Renin-angiotensin system inhibitor
DG01501 Angiotensin-converting enzyme inhibitor
D00383 Trandolapril
DG03231 Antihypertensive
DG01501 Angiotensin-converting enzyme inhibitor
D00383 Trandolapril
Drug classes [BR:br08332]
Cardiovascular agent
DG01501 Angiotensin-converting enzyme inhibitor
D00383 Trandolapril
DG03231 Antihypertensive
D00383 Trandolapril
Target-based classification of drugs [BR:br08310]
Enzymes
Hydrolases (EC3)
Peptidyl-dipeptidases
ACE (CD143)
D00383 Trandolapril (JAN/USP/INN) <JP/US>
Prodrugs [br08324.html]
D00383
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 31
1 N1y N 28.3850 -18.5792
2 C1y C 29.6683 -19.1392
3 C1y C 28.5425 -17.1850
4 C5a C 27.1775 -19.2850
5 C1y C 30.6075 -18.1008
6 C1x C 30.1000 -20.4692
7 C1x C 29.9134 -16.8933
8 C6a C 28.5308 -15.7792
9 C1c C 25.9642 -18.5850
10 O5a O 27.1834 -20.6850
11 C1x C 31.9784 -18.3984
12 C1x C 31.4709 -20.7667
13 O6a O 29.7326 -15.0675
14 O6a O 27.3116 -15.0908
15 N1b N 24.7508 -19.2850
16 C1a C 25.9699 -17.1850
17 C1x C 32.4042 -19.7284
18 C1c C 23.5432 -18.5909
19 C1b C 22.3300 -19.2967
20 C7a C 23.5375 -17.1909
21 C1b C 21.1167 -18.6083
22 O7a O 24.7508 -16.4909
23 O6a O 22.3183 -16.4966
24 C8y C 19.9092 -19.2967
25 C1b C 24.7450 -15.0908
26 C8x C 19.9092 -20.7084
27 C8x C 18.7074 -18.6083
28 C1a C 23.5317 -14.3966
29 C8x C 18.7074 -21.4141
30 C8x C 17.4883 -19.2967
31 C8x C 17.4883 -20.7084
BOND 33
1 1 2 1
2 1 3 1
3 1 4 1
4 2 5 1
5 2 6 1
6 3 7 1
7 3 8 1 #Down
8 4 9 1
9 4 10 2
10 5 11 1
11 6 12 1
12 8 13 1
13 8 14 2
14 9 15 1
15 9 16 1 #Up
16 11 17 1
17 15 18 1
18 18 19 1
19 18 20 1 #Up
20 19 21 1
21 20 22 1
22 20 23 2
23 21 24 1
24 22 25 1
25 24 26 1
26 24 27 2
27 25 28 1
28 26 29 2
29 27 30 1
30 29 31 1
31 5 7 1
32 12 17 1
33 30 31 2
|
|---|
